47 related articles for article (PubMed ID: 9166796)
1. Two populations of the estrogen receptor separated and characterized using aqueous two-phase partitioning.
Fritsch M; Anderson I; Leary CM; Gorski J
Biochemistry; 1997 May; 36(20):6230-42. PubMed ID: 9166796
[TBL] [Abstract][Full Text] [Related]
2. Expression and cellular localization of naturally occurring beta estrogen receptors in uterine and mammary cell lines.
Monje P; Boland R
J Cell Biochem; 2002; 86(1):136-44. PubMed ID: 12112024
[TBL] [Abstract][Full Text] [Related]
3. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
4. A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain.
Fritsch M; Leary CM; Furlow JD; Ahrens H; Schuh TJ; Mueller GC; Gorski J
Biochemistry; 1992 Jun; 31(23):5303-11. PubMed ID: 1606154
[TBL] [Abstract][Full Text] [Related]
5. Overproduction of full-length and truncated human estrogen receptors in Escherichia coli.
Ahrens H; Schuh TJ; Rainish BL; Furlow JD; Gorski J; Mueller GC
Receptor; 1992; 2(2):77-92. PubMed ID: 1472947
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional suppression of the estrogen receptor by truncated estrogen receptor-alpha.
Ikeda M; Okai M; Miyoshi T; Tone S; Minatogawa Y
Horm Metab Res; 2002 Aug; 34(8):425-30. PubMed ID: 12198596
[TBL] [Abstract][Full Text] [Related]
7. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.
Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
Oncogene; 2001 Jan; 20(1):77-87. PubMed ID: 11244506
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium.
Hunter DS; Hodges LC; Vonier PM; Fuchs-Young R; Gottardis MM; Walker CL
Cancer Res; 1999 Jul; 59(13):3090-9. PubMed ID: 10397250
[TBL] [Abstract][Full Text] [Related]
10. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
11. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha.
Maggiolini M; Donzé O; Jeannin E; Andò S; Picard D
Cancer Res; 1999 Oct; 59(19):4864-9. PubMed ID: 10519397
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
13. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
Carlson KE; Choi I; Gee A; Katzenellenbogen BS; Katzenellenbogen JA
Biochemistry; 1997 Dec; 36(48):14897-905. PubMed ID: 9398213
[TBL] [Abstract][Full Text] [Related]
14. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
15. Characterization of stably transfected fusion protein GFP-estrogen receptor-alpha in MCF-7 human breast cancer cells.
Zhao H; Hart LL; Keller U; Holth LT; Davie JR
J Cell Biochem; 2002; 86(2):365-75. PubMed ID: 12112006
[TBL] [Abstract][Full Text] [Related]
16. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
[TBL] [Abstract][Full Text] [Related]
17. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
18. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC
Oncogene; 2000 Jan; 19(4):490-7. PubMed ID: 10698518
[TBL] [Abstract][Full Text] [Related]
19. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
Wiese TE; Polin LA; Palomino E; Brooks SC
J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533
[TBL] [Abstract][Full Text] [Related]
20. Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer.
Bagatell R; Khan O; Paine-Murrieta G; Taylor CW; Akinaga S; Whitesell L
Clin Cancer Res; 2001 Jul; 7(7):2076-84. PubMed ID: 11448926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]